戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 Ten patients had locally advanced BCC; 2 had basal cell nevus syndrome.
2 nic dystrophy, neurofibromatosis type 2, and basal cell nevus syndrome.
3 after mutational inactivation of PTCH in the basal cell nevus syndrome.
4 ls, without other features characteristic of basal cell nevus syndrome.
5 w basal-cell carcinomas in patients with the basal-cell nevus syndrome.
6 following mutational inactivation of PTCH in basal-cell nevus syndrome.
7 basal-cell carcinoma growth in patients with basal-cell nevus syndrome.
8 ell carcinoma tumour burden in patients with basal-cell nevus syndrome.
9 D (PTC) are found in human patients with the basal cell nevus syndrome, a disease causing development
10 the PATCHED gene (PTCH) in patients with the basal-cell nevus syndrome, a hereditary disease characte
11 togenic keratocysts are one component of the basal cell nevus syndrome and all patients with odontoge
12 d or metastatic orbital or periocular BCC or basal cell nevus syndrome and can obviate orbital exente
13             After exclusion of patients with basal cell nevus syndrome and immunocompromise, 1284 pat
14  most exons of the gene in patients with the basal cell nevus syndrome and in sporadic basal cell car
15 26 sporadic basal cell carcinomas, and seven basal cell nevus syndrome-associated basal cell carcinom
16 lacebo-controlled trial in patients with the basal-cell nevus syndrome at three clinical centers from
17 ost BCCs are sporadic, rare individuals with basal cell nevus syndrome (BCNS) harbor germline defects
18                                Patients with basal cell nevus syndrome (BCNS) have a greater risk of
19                    Importance: Patients with basal cell nevus syndrome (BCNS) have a greater risk of
20                                          The basal cell nevus syndrome (BCNS) is characterized by dev
21                                              Basal cell nevus syndrome (BCNS), is a hereditary condit
22                                 In addition, basal cell nevus syndrome (BCNS), or Gorlin syndrome, wh
23 he jaw affect more than 65% of patients with basal cell nevus syndrome (BCNS).
24 umor suppressor protein that is defective in basal cell nevus syndrome (BCNS).
25 ing SHH in the skin develop many features of basal cell nevus syndrome, demonstrating that SHH is suf
26  from studies of three hereditary syndromes: basal cell nevus syndrome, familial melanoma/dysplastic
27 nt assignment was stratified by diagnosis of basal-cell nevus syndrome, geographical region, and immu
28                                Patients with basal cell nevus syndrome have a high incidence of multi
29 utations located in eight exons in 13 of the basal cell nevus syndrome patients and in three of the t
30 rmation polymorphism analysis of DNA from 86 basal cell nevus syndrome probands, 26 sporadic basal ce
31 nical follow-up time, immunosuppression, and basal cell nevus syndrome status.
32 .89-16.97; P < .001), accounting for age and basal cell nevus syndrome status.
33 d or metastatic orbital or periocular BCC or basal cell nevus syndrome treated with the Hedgehog path
34 e option for patients such as those with the basal cell nevus syndrome who are destined to develop la
35  basal-cell carcinomas, including those with basal-cell nevus syndrome, who had one or more histopath
36 l we enrolled patients aged 35-75 years with basal-cell nevus syndrome with at least ten surgically e

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。